Ryman Healthcare Limited (RYM.NZ)
NZD 4.38
(-0.45%)
NZD 4.38
(-0.45%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 550.77 Million | 542.76 Million | 535.97 Million | 375.94 Million | 414.88 Million | 370.42 Million |
| Net Income | 4.77 Million | 257.83 Million | 692.87 Million | 423.06 Million | 264.7 Million | 325.98 Million |
| Depreciation & Amortization | 43.8 Million | 46.59 Million | 35.69 Million | 32.36 Million | 28.61 Million | 23.12 Million |
| Deferred income taxes | -149.7 Million | -51.64 Million | 29.2 Million | -12.56 Million | -93.56 Million | 3.42 Million |
| Stock-based compensation | 2.93 Million | - | - | - | - | - |
| Change in working capital | 705.79 Million | 663.64 Million | 570.01 Million | 391.05 Million | 392.15 Million | 340.46 Million |
| Other non-cash items | 119.72 Million | -194.82 Million | -527.14 Million | -219.67 Million | 19.86 Million | -236.51 Million |
| Investing Cash Flow | -734.35 Million | -1.03 Billion | -787.31 Million | -844.47 Million | -713.48 Million | -554.67 Million |
| Investments in PPE | -172.19 Million | -324.2 Million | -298.63 Million | -228.87 Million | -274.88 Million | -157.17 Million |
| Acquisitions | 15.28 Million | - | - | - | - | - |
| Investment purchases | -582.55 Million | -608.78 Million | -434.39 Million | -577.5 Million | -401.61 Million | -364.18 Million |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 5.11 Million | -106.87 Million | -54.28 Million | -38.09 Million | -36.98 Million | -33.31 Million |
| Financing Cash Flow | 197.5 Million | 388.6 Million | 209.47 Million | 417.15 Million | 298.06 Million | 153.25 Million |
| Debt repayment | -201.21 Million | -436.72 Million | -326.91 Million | -36.71 Million | -421.87 Million | -266.71 Million |
| Dividends payments | - | -68.08 Million | -112 Million | -107.5 Million | -117 Million | -108.5 Million |
| Common Stock Repurchased | -352 Thousand | 2.64 Million | -2.78 Million | -3.02 Million | -4.89 Million | -4.96 Million |
| Common Stock Issuance | -352 Thousand | 876.03 Million | -326.91 Million | 566.87 Million | -421.87 Million | -266.71 Million |
| Other Financing Activities | -3.36 Million | 14.73 Million | 978.08 Million | -2.47 Million | 1.26 Billion | 800.15 Million |
| Accounts receivables | -95.59 Million | -138.4 Million | -202.84 Million | -151.68 Million | -145.17 Million | -41.98 Million |
| Accounts payables | -2.65 Million | 41.11 Million | 9.17 Million | 4.84 Million | 5.5 Million | 2.16 Million |
| Inventory | 12.23 Million | 11.63 Million | 390 Thousand | -26.73 Million | - | - |
| Other working capital | 791.8 Million | 749.29 Million | 763.29 Million | 564.63 Million | 531.82 Million | 380.28 Million |
| Cash at beginning of period | 27.87 Million | 28.3 Million | 20.17 Million | 34.37 Million | 449.79 Million | - |
| Cash at end of period | 41.8 Million | 27.87 Million | 28.3 Million | 20.17 Million | 34.37 Million | -401.42 Million |
| Capital Expenditure | -172.19 Million | -324.2 Million | -298.63 Million | -228.87 Million | -274.88 Million | -157.17 Million |
| Effect of forex changes on cash | - | 108.06 Million | 50 Million | 37.17 Million | -414.88 Million | -370.42 Million |
| Net cash flow / Change in cash | 13.93 Million | -430 Thousand | 8.13 Million | -14.2 Million | -415.41 Million | -401.42 Million |
| Free Cash Flow | 378.58 Million | 218.55 Million | 237.33 Million | 147.06 Million | 139.99 Million | 213.25 Million |
| Breakdown | 2024 FY | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 4.77 Million | -90.95 Million | -90.95 Million | 186.68 Million | 93.34 Million | 63.85 Million |
| Depreciation & Amortization | 43.8 Million | 770.5 Thousand | 770.5 Thousand | 26.18 Million | 13.09 Million | 23.6 Million |
| Deferred income taxes | -149.7 Million | -106.45 Million | - | -43.25 Million | - | -74.95 Million |
| Stock-based compensation | 2.93 Million | 865.5 Thousand | 865.5 Thousand | 600 Thousand | 600 Thousand | - |
| Change in working capital | 705.79 Million | 179.56 Million | 179.56 Million | 330.66 Million | 153.86 Million | 387.54 Million |
| Other non-cash items | 119.72 Million | 70.03 Million | 70.03 Million | -156.8 Million | -91.94 Million | -83.13 Million |
| Investing Cash Flow | -734.35 Million | -172.88 Million | -172.88 Million | -442.76 Million | -248.14 Million | -432.83 Million |
| Investments in PPE | -172.19 Million | -39.86 Million | -39.86 Million | -139.65 Million | -92.34 Million | -120 Million |
| Acquisitions | 15.28 Million | 15.28 Million | - | - | - | - |
| Investment purchases | -582.55 Million | -279.37 Million | - | -303.17 Million | - | -313.76 Million |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 5.11 Million | -133.02 Million | -133.02 Million | 69 Thousand | -155.79 Million | 936 Thousand |
| Financing Cash Flow | 197.5 Million | 16.85 Million | 16.85 Million | 163.78 Million | 81.89 Million | 94.17 Million |
| Debt repayment | -201.21 Million | -35.21 Million | - | -166 Million | - | -672.79 Million |
| Dividends payments | - | -352 Thousand | - | -352 Thousand | - | -89 Thousand |
| Common Stock Repurchased | -352 Thousand | - | - | - | - | -401 Thousand |
| Common Stock Issuance | -352 Thousand | -352 Thousand | - | - | - | 875.23 Million |
| Other Financing Activities | -3.36 Million | 16.85 Million | 16.85 Million | 81.89 Million | 81.89 Million | -106.59 Million |
| Accounts receivables | -95.59 Million | -4.53 Million | -4.53 Million | -16.51 Million | 25.08 Million | 23.3 Million |
| Accounts payables | -2.65 Million | -6.2 Million | - | 3.54 Million | - | 39.6 Million |
| Inventory | 12.23 Million | 2.98 Million | 2.98 Million | 6.26 Million | 3.13 Million | 8.05 Million |
| Other working capital | 791.8 Million | 181.12 Million | 181.12 Million | 337.36 Million | 125.64 Million | 316.58 Million |
| Cash at beginning of period | 27.87 Million | 33.29 Million | - | 27.87 Million | - | 25.87 Million |
| Cash at end of period | 41.8 Million | 41.8 Million | 4.25 Million | 33.29 Million | 2.7 Million | 27.87 Million |
| Capital Expenditure | -172.19 Million | -39.86 Million | -39.86 Million | -139.65 Million | -92.34 Million | -120 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 13.93 Million | 8.51 Million | 4.25 Million | 5.41 Million | 2.7 Million | 2 Million |
| Free Cash Flow | 378.58 Million | 120.42 Million | 120.42 Million | 144.74 Million | 76.61 Million | 220.65 Million |
AZZ
LL
002443
0772
ACBD
HERO